Evidence map›Paper›PMID 26609251›Full record

ArticleClinical medicine insights. Reproductive health2015

The IMSI Procedure Improves Laboratory and Clinical Outcomes Without Compromising the Aneuploidy Rate When Compared to the Classical ICSI Procedure.

Daniel Luna, Roly Hilario, Julio Dueñas-Chacón, Rocío Romero, Patricia Zavala, Lucy Villegas, Javier García-Ferreyra

Open access · goldAbstract read
In one paragraph

Article in Clinical medicine insights. Reproductive health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. IMSI-Guidelines for Sperm Quality Assessment.Diagnostics (Basel, Switzerland) · 2022
    Guideline
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Role of Antioxidants in Assisted Reproductive Techniques.The world journal of men's health · 2017
    Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Daniel LunaFERTILAB Laboratory of Assisted Reproduction, Lima, Perú.
Roly HilarioPROCREAR Fertility Center, Lima, Perú.
Julio Dueñas-ChacónPROCREAR Fertility Center, Lima, Perú.
Rocío RomeroPROCREAR Fertility Center, Lima, Perú.
Patricia ZavalaPROCREAR Fertility Center, Lima, Perú.
Lucy VillegasFERTILAB Laboratory of Assisted Reproduction, Lima, Perú.
Javier García-FerreyraFERTILAB Laboratory of Assisted Reproduction, Lima, Perú.
Fertility Centers of Illinois · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe intracytoplasmic morphologically selected sperm injection (IMSI) procedure has been associated with better laboratory and clinical outcomes in assisted reproduction technologies. Less information is available regarding the relationship between embryo aneuploidy rate and the IMSI procedure. The aim of this study is to compare the clinical outcomes and chromosomal status of IMSI-derived embryos with those obtained from intracytoplasmic sperm injection (ICSI) in order to establish a clearer view of the benefits of IMSI in infertile patients.

methodsWe retrospectively analyzed a total of 11 cycles of IMSI and 20 cycles of ICSI with preimplantation genetic diagnosis. The fertilization rate, cleavage rate, embryo quality, blastocyst development, aneuploidy rate, pregnancy rate, implantation rate, and miscarriage rate were compared between the groups.

resultsSimilar rates of fertilization (70% and 73%), cleavage (98% and 100%), and aneuploidy (76.9% and 70.9%) were observed in the IMSI and ICSI groups, respectively. The IMSI group had significantly more good quality embryos at day 3 (95% vs 73%), higher blastocyst development rates (33% vs 19%), and greater number of hatching blastocysts (43% vs 28%), cycles with at least one blastocyst at day 5 (55% vs 35%), and blastocysts with good trophoectoderm morphology (21% vs 6%) compared with the ICSI group (P < 0.001). Significantly higher implantation rates were observed in the IMSI group compared with the ICSI group (57% vs 27%; P < 0.05). Pregnancy and miscarriage rates were similar in both groups (80% vs 50% and 0% vs 33%, respectively).

conclusionThe IMSI procedure significantly improves the embryo quality/development by increasing the implantation rates without affecting the chromosomal status of embryos. There is a tendency for the IMSI procedure to enhance the pregnancy rates and lower the miscarriage rates when compared with ICSI.

Indexed as

aneuploidyICSIimplantationIMSIMSOMEpregnancy

Identifiers

PMID26609251
PMCPMC4644143
OpenAlexW2101173446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.